ANI Pharmaceuticals, Inc.ANIPNASDAQ

Revenue (LTM)

$883M

+43.8% YoY

Net Income (LTM)

$78M

+522.9% YoY

Free Cash Flow

$171M

Revenue CAGR (5Y)

+42.2%

Marginsimproving

FCF$0.2B

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	216	316↑46.4%	487↑53.9%	614↑26.2%	883↑43.8%
Gross Profit	116	178↑53.7%	305↑71.9%	364↑19.3%	451↑23.7%
Operating Income	-40	-35↑11.3%	47↑233.1%	1↓98.8%	81↑13809.2%
Net Income	-43	-48↓12.4%	19↑139.2%	-19↓198.6%	78↑522.9%
EBITDA	3	25↑703.6%	107↑325.7%	63↓40.8%	207↑228.4%
EPS Diluted	-3.40	-3.05↑10.3%	0.94↑130.8%	-1.04↓210.6%	3.32↑419.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	100	48↓51.9%	221↑358.5%	145↓34.5%	286↑97.1%
Total Current Assets	322	344↑7.0%	520↑51.0%	528↑1.5%	753↑42.7%
Total Assets	772	760↓1.5%	904↑19.0%	1,284↑41.9%	1,440↑12.2%
Total Current Liabilities	88	99↑13.6%	145↑46.3%	194↑33.1%	278↑43.6%
Total Liabilities	413	422↑2.1%	447↑6.0%	855↑91.4%	900↑5.2%
Total Equity	359	339↓5.6%	458↑35.2%	429↓6.4%	541↑26.2%
Total Debt	287	287↓0.3%	286↓0.3%	624↑118.5%	325↓47.9%
Net Debt	187	238↑27.4%	65↓72.9%	479↑642.4%	40↓91.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	3	-31↓1039.3%	119↑481.2%	64↓46.2%	185↑189.3%
Capital Expenditure	-24	-16↑30.4%	-19↓12.5%	-17↑8.4%	-14↑18.4%
Free Cash Flow	-20	-48↓134.6%	100↑310.8%	47↓53.1%	171↑264.2%
Stock-Based Comp	10	15↑39.2%	21↑41.5%	29↑42.1%	38↑29.3%
Net Change in Cash	92	-52↓156.3%	168↑422.4%	-76↓145.4%	141↑284.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance